{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.21037/ATM.2019.10.23",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/cmttdb",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Database portal",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3360"
        },
        {
          "@id": "edam:topic_3379"
        },
        {
          "@id": "edam:topic_3068"
        },
        {
          "@id": "edam:topic_2640"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6944590",
        "pubmed:31930068",
        {
          "@id": "https://doi.org/10.21037/ATM.2019.10.23"
        }
      ],
      "sc:description": "CMTTdb (The Cancer Molecular-Targeted Therapy database) is an integrated database to store relevant information about molecular targeted agents as well as their combinatorial approaches in clinical trials and studies for cancer treatment. It contains the information from public available clinical trials to obtain the clinical agents, their corresponding targets, cancer subtypes, biomarkers, clinical features of the patients, as well as the treatment modalities (monotherapy or combinatorial therapies)",
      "sc:featureList": {
        "@id": "edam:operation_2422"
      },
      "sc:name": "CMTTdb",
      "sc:url": "http://www.biosino.org/CMTTdb"
    }
  ]
}